SCHEMBL20122396

SCHEMBL20122396

CCOC(=O)[C@H](CSC(=O)OCOC(C)=O)NC(=O)C(C)(C)SC(=O)OCOC(C)=O

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ALDH1A1 P00352 4/20 0.32
▸ MAPT P10636 3/20 0.32
▸ LMNA P02545 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ CAD P27708 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ METAP2 P50579 1/20 0.30
▸ METAP1 P53582 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ PKM P14618 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ ALOX12 P18054 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122551 0.90 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL20122397 0.90 — —
SCHEMBL20122523 0.89 CYP1A2 (0.37) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL20122591 0.89 CYP1A2 (0.37) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL20122401 0.88 CYP1A2 (0.33) CYP1A2CYP2C9CYP2C19HTT
SCHEMBL20122446 0.88 — —
SCHEMBL20122400 0.87 — —
SCHEMBL20122429 0.86 CYP1A2 (0.33) CYP1A2CYP2C9CYP2C19HTTALDH1A1
SCHEMBL20122568 0.86 CYP1A2 (0.38) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL20122520 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback